非小細胞肺がん治療薬市場は、2022年から2027年の間に159億3,689万米ドル成長すると予測されており、予測期間中に9.25%のCAGRで加速すると予測されています。非小細胞肺がん治療薬市場に関するレポートは、全体的な分析、市場規模、予測、傾向、成長ドライバー、課題に加えて、約25のベンダーをカバーするベンダー分析を提供します。
このレポートは、現在の市場シナリオ、最新の傾向と推進力、および全体的な市場環境に関する最新の分析を提供します。市場は、非小細胞肺がんの有病率と発生率の増加、強力な医薬品パイプラインと最近の医薬品承認、患者支援プログラムの利用可能性によって牽引されています。
この調査は、併用療法の導入と承認が、今後数年間の非小細胞肺がん治療薬市場の成長を促進する主な理由の1つであることを特定しています。また、非小細胞肺がん治療薬を開発するための戦略的提携の増加や、費用対効果の高い治療法開発のための予測バイオマーカーの使用は、市場での大きな需要につながるでしょう。
堅牢なベンダー分析は、クライアントが市場での地位を向上させるのに役立つように設計されています。また、非小細胞肺がん治療薬市場分析レポートには、市場の成長に影響を与える今後の傾向と課題に関する情報が含まれています。これは、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。
この調査は、業界の主要参加者からの意見を含む一次情報と二次情報を客観的に組み合わせて実施されました。このレポートには、主要ベンダーの分析に加えて、包括的な市場とベンダーの状況が含まれています。
このレポートは、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析による複数のソースからのデータの調査、合成、合計により、市場の詳細な全体像を提示します。業界の主要な影響力を持つ企業を特定することで、さまざまな市場の側面を示します。提示されたデータは包括的で信頼性が高く、一次および二次の両方にわたる広範な研究の結果です。市場調査レポートは、正確な市場の成長を予測するための定性的および定量的調査を使用した、完全な競争状況と詳細なベンダー選択方法論および分析を提供します。
目次
Table of Contents
1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
Exhibit 06: Executive Summary - Chart on Market Segmentation by Product
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
4.1 Global non-small cell lung cancer drugs market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on global non-small cell lung cancer drugs market 2017 - 2021 ($ million)
4.2 Type Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Type Segment 2017 - 2021 ($ million)
4.3 Product Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Product Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
6 Market Segmentation by Type
6.1 Market segments
Exhibit 30: Chart on Type - Market share 2022-2027 (%)
Exhibit 31: Data Table on Type - Market share 2022-2027 (%)
6.2 Comparison by Type
Exhibit 32: Chart on Comparison by Type
Exhibit 33: Data Table on Comparison by Type
6.3 Adenocarcinoma - Market size and forecast 2022-2027
Exhibit 34: Chart on Adenocarcinoma - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Adenocarcinoma - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Adenocarcinoma - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Adenocarcinoma - Year-over-year growth 2022-2027 (%)
6.4 Squamous cell carcinoma - Market size and forecast 2022-2027
Exhibit 38: Chart on Squamous cell carcinoma - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Squamous cell carcinoma - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Squamous cell carcinoma - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Squamous cell carcinoma - Year-over-year growth 2022-2027 (%)
6.5 Large cell carcinoma - Market size and forecast 2022-2027
Exhibit 42: Chart on Large cell carcinoma - Market size and forecast 2022-2027 ($ million)
Exhibit 43: Data Table on Large cell carcinoma - Market size and forecast 2022-2027 ($ million)
Exhibit 44: Chart on Large cell carcinoma - Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on Large cell carcinoma - Year-over-year growth 2022-2027 (%)
6.6 Market opportunity by Type
Exhibit 46: Market opportunity by Type ($ million)
Exhibit 47: Data Table on Market opportunity by Type ($ million)
7 Market Segmentation by Product
7.1 Market segments
Exhibit 48: Chart on Product - Market share 2022-2027 (%)
Exhibit 49: Data Table on Product - Market share 2022-2027 (%)
7.2 Comparison by Product
Exhibit 50: Chart on Comparison by Product
Exhibit 51: Data Table on Comparison by Product
7.3 Biologics - Market size and forecast 2022-2027
Exhibit 52: Chart on Biologics - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Data Table on Biologics - Market size and forecast 2022-2027 ($ million)
Exhibit 54: Chart on Biologics - Year-over-year growth 2022-2027 (%)
Exhibit 55: Data Table on Biologics - Year-over-year growth 2022-2027 (%)
7.4 Small molecule targeted therapy - Market size and forecast 2022-2027
Exhibit 56: Chart on Small molecule targeted therapy - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Data Table on Small molecule targeted therapy - Market size and forecast 2022-2027 ($ million)
Exhibit 58: Chart on Small molecule targeted therapy - Year-over-year growth 2022-2027 (%)
Exhibit 59: Data Table on Small molecule targeted therapy - Year-over-year growth 2022-2027 (%)
7.5 Chemotherapy - Market size and forecast 2022-2027
Exhibit 60: Chart on Chemotherapy - Market size and forecast 2022-2027 ($ million)
Exhibit 61: Data Table on Chemotherapy - Market size and forecast 2022-2027 ($ million)
Exhibit 62: Chart on Chemotherapy - Year-over-year growth 2022-2027 (%)
Exhibit 63: Data Table on Chemotherapy - Year-over-year growth 2022-2027 (%)
7.6 Market opportunity by Product
Exhibit 64: Market opportunity by Product ($ million)
Exhibit 65: Data Table on Market opportunity by Product ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 67: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 69: Chart on Geographic comparison
Exhibit 70: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 71: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 73: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 74: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 77: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 81: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 87: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 88: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 89: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 Germany - Market size and forecast 2022-2027
Exhibit 91: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 92: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 93: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.9 China - Market size and forecast 2022-2027
Exhibit 95: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 96: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 97: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on China - Year-over-year growth 2022-2027 (%)
9.10 Canada - Market size and forecast 2022-2027
Exhibit 99: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 100: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 101: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 102: Data Table on Canada - Year-over-year growth 2022-2027 (%)
9.11 UK - Market size and forecast 2022-2027
Exhibit 103: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 104: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 105: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 106: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 107: Market opportunity By Geographical Landscape ($ million)
Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 109: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 111: Overview on factors of disruption
11.4 Industry risks
Exhibit 112: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 113: Vendors covered
12.2 Market positioning of vendors
Exhibit 114: Matrix on vendor position and classification
12.3 AbbVie Inc.
Exhibit 115: AbbVie Inc. - Overview
Exhibit 116: AbbVie Inc. - Product / Service
Exhibit 117: AbbVie Inc. - Key news
Exhibit 118: AbbVie Inc. - Key offerings
12.4 Amgen Inc.
Exhibit 119: Amgen Inc. - Overview
Exhibit 120: Amgen Inc. - Product / Service
Exhibit 121: Amgen Inc. - Key offerings
12.5 Astellas Pharma Inc.
Exhibit 122: Astellas Pharma Inc. - Overview
Exhibit 123: Astellas Pharma Inc. - Product / Service
Exhibit 124: Astellas Pharma Inc. - Key news
Exhibit 125: Astellas Pharma Inc. - Key offerings
12.6 AstraZeneca PLC
Exhibit 126: AstraZeneca PLC - Overview
Exhibit 127: AstraZeneca PLC - Product / Service
Exhibit 128: AstraZeneca PLC - Key news
Exhibit 129: AstraZeneca PLC - Key offerings
12.7 Bayer AG
Exhibit 130: Bayer AG - Overview
Exhibit 131: Bayer AG - Business segments
Exhibit 132: Bayer AG - Key news
Exhibit 133: Bayer AG - Key offerings
Exhibit 134: Bayer AG - Segment focus
12.8 BeiGene Ltd.
Exhibit 135: BeiGene Ltd. - Overview
Exhibit 136: BeiGene Ltd. - Business segments
Exhibit 137: BeiGene Ltd. - Key offerings
Exhibit 138: BeiGene Ltd. - Segment focus
12.9 Boehringer Ingelheim International GmbH
Exhibit 139: Boehringer Ingelheim International GmbH - Overview
Exhibit 140: Boehringer Ingelheim International GmbH - Business segments
Exhibit 141: Boehringer Ingelheim International GmbH - Key news
Exhibit 142: Boehringer Ingelheim International GmbH - Key offerings
Exhibit 143: Boehringer Ingelheim International GmbH - Segment focus
12.10 Bristol Myers Squibb Co.
Exhibit 144: Bristol Myers Squibb Co. - Overview
Exhibit 145: Bristol Myers Squibb Co. - Product / Service
Exhibit 146: Bristol Myers Squibb Co. - Key news
Exhibit 147: Bristol Myers Squibb Co. - Key offerings
12.11 Eli Lilly and Co.
Exhibit 148: Eli Lilly and Co. - Overview
Exhibit 149: Eli Lilly and Co. - Product / Service
Exhibit 150: Eli Lilly and Co. - Key news
Exhibit 151: Eli Lilly and Co. - Key offerings
12.12 F. Hoffmann La Roche Ltd.
Exhibit 152: F. Hoffmann La Roche Ltd. - Overview
Exhibit 153: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 154: F. Hoffmann La Roche Ltd. - Key news
Exhibit 155: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 156: F. Hoffmann La Roche Ltd. - Segment focus
12.13 Innovent Biologics Inc.
Exhibit 157: Innovent Biologics Inc. - Overview
Exhibit 158: Innovent Biologics Inc. - Product / Service
Exhibit 159: Innovent Biologics Inc. - Key offerings
12.14 Merck KGaA
Exhibit 160: Merck KGaA - Overview
Exhibit 161: Merck KGaA - Business segments
Exhibit 162: Merck KGaA - Key news
Exhibit 163: Merck KGaA - Key offerings
Exhibit 164: Merck KGaA - Segment focus
12.15 Ono Pharmaceutical Co. Ltd.
Exhibit 165: Ono Pharmaceutical Co. Ltd. - Overview
Exhibit 166: Ono Pharmaceutical Co. Ltd. - Product / Service
Exhibit 167: Ono Pharmaceutical Co. Ltd. - Key offerings
12.16 Pfizer Inc.
Exhibit 168: Pfizer Inc. - Overview
Exhibit 169: Pfizer Inc. - Product / Service
Exhibit 170: Pfizer Inc. - Key news
Exhibit 171: Pfizer Inc. - Key offerings
12.17 Takeda Pharmaceutical Co. Ltd.
Exhibit 172: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibit 173: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibit 174: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibit 175: Takeda Pharmaceutical Co. Ltd. - Key offerings
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 176: Inclusions checklist
Exhibit 177: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 178: Currency conversion rates for US$
13.4 Research methodology
Exhibit 179: Research methodology
Exhibit 180: Validation techniques employed for market sizing
Exhibit 181: Information sources
13.5 List of abbreviations
Exhibit 182: List of abbreviations
Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Type
Exhibits6: Executive Summary - Chart on Market Segmentation by Product
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on global non-small cell lung cancer drugs market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Type Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Product Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Type - Market share 2022-2027 (%)
Exhibits31: Data Table on Type - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Type
Exhibits33: Data Table on Comparison by Type
Exhibits34: Chart on Adenocarcinoma - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Adenocarcinoma - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Adenocarcinoma - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Adenocarcinoma - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Squamous cell carcinoma - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Squamous cell carcinoma - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Squamous cell carcinoma - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Squamous cell carcinoma - Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Large cell carcinoma - Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Large cell carcinoma - Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Large cell carcinoma - Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Large cell carcinoma - Year-over-year growth 2022-2027 (%)
Exhibits46: Market opportunity by Type ($ million)
Exhibits47: Data Table on Market opportunity by Type ($ million)
Exhibits48: Chart on Product - Market share 2022-2027 (%)
Exhibits49: Data Table on Product - Market share 2022-2027 (%)
Exhibits50: Chart on Comparison by Product
Exhibits51: Data Table on Comparison by Product
Exhibits52: Chart on Biologics - Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on Biologics - Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on Biologics - Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Biologics - Year-over-year growth 2022-2027 (%)
Exhibits56: Chart on Small molecule targeted therapy - Market size and forecast 2022-2027 ($ million)
Exhibits57: Data Table on Small molecule targeted therapy - Market size and forecast 2022-2027 ($ million)
Exhibits58: Chart on Small molecule targeted therapy - Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Small molecule targeted therapy - Year-over-year growth 2022-2027 (%)
Exhibits60: Chart on Chemotherapy - Market size and forecast 2022-2027 ($ million)
Exhibits61: Data Table on Chemotherapy - Market size and forecast 2022-2027 ($ million)
Exhibits62: Chart on Chemotherapy - Year-over-year growth 2022-2027 (%)
Exhibits63: Data Table on Chemotherapy - Year-over-year growth 2022-2027 (%)
Exhibits64: Market opportunity by Product ($ million)
Exhibits65: Data Table on Market opportunity by Product ($ million)
Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits67: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits69: Chart on Geographic comparison
Exhibits70: Data Table on Geographic comparison
Exhibits71: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits103: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits104: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits105: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits106: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits107: Market opportunity By Geographical Landscape ($ million)
Exhibits108: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits109: Impact of drivers and challenges in 2022 and 2027
Exhibits110: Overview on Criticality of inputs and Factors of differentiation
Exhibits111: Overview on factors of disruption
Exhibits112: Impact of key risks on business
Exhibits113: Vendors covered
Exhibits114: Matrix on vendor position and classification
Exhibits115: AbbVie Inc. - Overview
Exhibits116: AbbVie Inc. - Product / Service
Exhibits117: AbbVie Inc. - Key news
Exhibits118: AbbVie Inc. - Key offerings
Exhibits119: Amgen Inc. - Overview
Exhibits120: Amgen Inc. - Product / Service
Exhibits121: Amgen Inc. - Key offerings
Exhibits122: Astellas Pharma Inc. - Overview
Exhibits123: Astellas Pharma Inc. - Product / Service
Exhibits124: Astellas Pharma Inc. - Key news
Exhibits125: Astellas Pharma Inc. - Key offerings
Exhibits126: AstraZeneca PLC - Overview
Exhibits127: AstraZeneca PLC - Product / Service
Exhibits128: AstraZeneca PLC - Key news
Exhibits129: AstraZeneca PLC - Key offerings
Exhibits130: Bayer AG - Overview
Exhibits131: Bayer AG - Business segments
Exhibits132: Bayer AG - Key news
Exhibits133: Bayer AG - Key offerings
Exhibits134: Bayer AG - Segment focus
Exhibits135: BeiGene Ltd. - Overview
Exhibits136: BeiGene Ltd. - Business segments
Exhibits137: BeiGene Ltd. - Key offerings
Exhibits138: BeiGene Ltd. - Segment focus
Exhibits139: Boehringer Ingelheim International GmbH - Overview
Exhibits140: Boehringer Ingelheim International GmbH - Business segments
Exhibits141: Boehringer Ingelheim International GmbH - Key news
Exhibits142: Boehringer Ingelheim International GmbH - Key offerings
Exhibits143: Boehringer Ingelheim International GmbH - Segment focus
Exhibits144: Bristol Myers Squibb Co. - Overview
Exhibits145: Bristol Myers Squibb Co. - Product / Service
Exhibits146: Bristol Myers Squibb Co. - Key news
Exhibits147: Bristol Myers Squibb Co. - Key offerings
Exhibits148: Eli Lilly and Co. - Overview
Exhibits149: Eli Lilly and Co. - Product / Service
Exhibits150: Eli Lilly and Co. - Key news
Exhibits151: Eli Lilly and Co. - Key offerings
Exhibits152: F. Hoffmann La Roche Ltd. - Overview
Exhibits153: F. Hoffmann La Roche Ltd. - Business segments
Exhibits154: F. Hoffmann La Roche Ltd. - Key news
Exhibits155: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits156: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits157: Innovent Biologics Inc. - Overview
Exhibits158: Innovent Biologics Inc. - Product / Service
Exhibits159: Innovent Biologics Inc. - Key offerings
Exhibits160: Merck KGaA - Overview
Exhibits161: Merck KGaA - Business segments
Exhibits162: Merck KGaA - Key news
Exhibits163: Merck KGaA - Key offerings
Exhibits164: Merck KGaA - Segment focus
Exhibits165: Ono Pharmaceutical Co. Ltd. - Overview
Exhibits166: Ono Pharmaceutical Co. Ltd. - Product / Service
Exhibits167: Ono Pharmaceutical Co. Ltd. - Key offerings
Exhibits168: Pfizer Inc. - Overview
Exhibits169: Pfizer Inc. - Product / Service
Exhibits170: Pfizer Inc. - Key news
Exhibits171: Pfizer Inc. - Key offerings
Exhibits172: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits173: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits174: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits175: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits176: Inclusions checklist
Exhibits177: Exclusions checklist
Exhibits178: Currency conversion rates for US$
Exhibits179: Research methodology
Exhibits180: Validation techniques employed for market sizing
Exhibits181: Information sources
Exhibits182: List of abbreviations
